Renal and cardiovascular metabolic impact caused by ketogenesis of the SGLT2 inhibitors
AP Vargas-Delgado, E Arteaga Herrera… - International Journal of …, 2023 - mdpi.com
Sodium–glucose cotransporter type 2 inhibitors (SGLT2i) are glycosuric drugs that were
originally developed for the treatment of type 2 diabetes mellitus (T2DM). There is a …
originally developed for the treatment of type 2 diabetes mellitus (T2DM). There is a …
[HTML][HTML] Multifaceted relationship between diabetes and kidney diseases: Beyond diabetes
P Esposito, D Picciotto, F Cappadona… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Diabetes mellitus is one of the most common causes of chronic kidney disease. Kidney
involvement in patients with diabetes has a wide spectrum of clinical presentations ranging …
involvement in patients with diabetes has a wide spectrum of clinical presentations ranging …
Sex differences in diabetic foot ulcer severity and outcome in Belgium
AS Vanherwegen, P Lauwers, A Lavens, K Doggen… - PLoS …, 2023 - journals.plos.org
Background Sex differences are increasingly recognized to play an important role in the
epidemiology, treatment and outcomes of many diseases. This study aims to describe …
epidemiology, treatment and outcomes of many diseases. This study aims to describe …
Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and diabetic kidney disease in patients with …
J Pan, C Li, J Zhang, Z Sun, X Yu, Q Wan… - Lipids in health and …, 2024 - Springer
Background This paper investigated the link between non-high-density lipoprotein
cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and diabetic kidney disease …
cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and diabetic kidney disease …
Failure to control conventional cardiovascular risk factors in women with type 2 diabetes might explain worse mortality
Introduction The standardised mortality rate (SMR) for people with diabetes in England is 1.5–
1.7, with differences in outcomes between sexes. There has been little work examining the …
1.7, with differences in outcomes between sexes. There has been little work examining the …
Amelioration of diabetic nephropathy in mice by a single intravenous injection of human mesenchymal stromal cells at early and later disease stages is associated …
J He, B Liu, X Du, Y Wei, D Kong, B Feng… - Stem Cell Research & …, 2024 - Springer
Background and aims Mesenchymal stromal cells (MSCs) a potentially effective disease-
modulating therapy for diabetic nephropathy (DN) but their clinical translation has been …
modulating therapy for diabetic nephropathy (DN) but their clinical translation has been …
Sex-related differences in cardiovascular disease risk profile in children and adolescents with type 1 diabetes
Cardiovascular disease (CVD) is the primary cause of higher and earlier morbidity and
mortality in people with type 1 diabetes (T1D) compared to people without diabetes. In …
mortality in people with type 1 diabetes (T1D) compared to people without diabetes. In …
Sex-related effects of gut microbiota in metabolic syndrome-related diabetic retinopathy
A García-Llorca, G Kararigas - Microorganisms, 2023 - mdpi.com
The metabolic syndrome (MetS) is a complex disease of metabolic abnormalities, including
obesity, insulin resistance, hypertension and dyslipidaemia, and it is associated with an …
obesity, insulin resistance, hypertension and dyslipidaemia, and it is associated with an …
Potential plasma metabolite biomarkers of diabetic nephropathy: untargeted metabolomics study
Diabetic nephropathy (DN) is one of the specific complications of diabetes mellitus and one
of the leading kidney-related disorders, often requiring renal replacement therapy. Currently …
of the leading kidney-related disorders, often requiring renal replacement therapy. Currently …
[HTML][HTML] Development of a machine learning-based model for the prediction and progression of diabetic kidney disease: A single centred retrospective study
Background Diabetic kidney disease (DKD) is a diabetic microvascular complication often
characterized by an unpredictable progression. Hence, early detection and recognition of …
characterized by an unpredictable progression. Hence, early detection and recognition of …